The Paul G. Allen Family Foundation supports launch of IDRI’s TB vaccine clinical program

A Phase 1 clinical trial of a new TB vaccine known as ID93/GLA-SE

Read the press release here.

Infectious Disease Research Institute

http://www.idri.org/

To subscribe to the Weekly Newsletter of new posts, enter your email here:


News

Published: Oct. 14, 2011, 7:41 p.m.

Last updated: Oct. 14, 2011, 7:48 p.m.

Tags: None

Print Share